| Proteotyping SARS-CoV-2 virus from nasopharyngeal swabs: a proof-of-concept focused on a 3 min mass spectrometry window D Gouveia, G Miotello, F Gallais, JC Gaillard, S Debroas, L Bellanger, ... Journal of Proteome Research 19 (11), 4407-4416, 2020 | 100 | 2020 |
| Shortlisting SARS‐CoV‐2 peptides for targeted studies from experimental data‐dependent acquisition tandem mass spectrometry data D Gouveia, L Grenga, JC Gaillard, F Gallais, L Bellanger, O Pible, ... Proteomics 20 (14), 2000107, 2020 | 71 | 2020 |
| Evaluation of sample preparation methods for fast proteotyping of microorganisms by tandem mass spectrometry K Hayoun, D Gouveia, L Grenga, O Pible, J Armengaud, B Alpha-Bazin Frontiers in microbiology 10, 1985, 2019 | 71 | 2019 |
| Pathogen proteotyping: a rapidly developing application of mass spectrometry to address clinical concerns L Grenga, O Pible, J Armengaud Clinical Mass Spectrometry 14, 9-17, 2019 | 61 | 2019 |
| Shotgun proteomics analysis of SARS-CoV-2-infected cells and how it can optimize whole viral particle antigen production for vaccines L Grenga, F Gallais, O Pible, JC Gaillard, D Gouveia, H Batina, ... Emerging Microbes & Infections 9 (1), 1712-1721, 2020 | 59 | 2020 |
| Adaptive Remodeling of the Bacterial Proteome by Specific Ribosomal Modification Regulates Pseudomonas Infection and Niche Colonisation RH Little, L Grenga, G Saalbach, AM Howat, S Pfeilmeier, E Trampari, ... PLoS genetics 12 (2), e1005837, 2016 | 50 | 2016 |
| The Escherichia coli FtsK functional domains involved in its interaction with its divisome protein partners L Grenga, G Luzi, L Paolozzi, P Ghelardini FEMS microbiology letters 287 (2), 163-167, 2008 | 43 | 2008 |
| One ligand, two regulators and three binding sites: How KDPG controls primary carbon metabolism in Pseudomonas R Campilongo, RKY Fung, RH Little, L Grenga, E Trampari, S Pepe, ... PLoS Genetics 13 (6), e1006839, 2017 | 42 | 2017 |
| Pan-genome analysis identifies intersecting roles for Pseudomonas specialized metabolites in potato pathogen inhibition A Pacheco-Moreno, FL Stefanato, JJ Ford, C Trippel, S Uszkoreit, ... Elife 10, e71900, 2021 | 37* | 2021 |
| Quick microbial molecular phenotyping by differential shotgun proteomics D Gouveia, L Grenga, O Pible, J Armengaud Environmental Microbiology 22 (8), 2996-3004, 2020 | 30 | 2020 |
| Quick change: post-transcriptional regulation in Pseudomonas L Grenga, RH Little, JG Malone FEMS microbiology letters 364 (14), fnx125, 2017 | 30 | 2017 |
| Factors modulating COVID-19: A mechanistic understanding based on the adverse outcome pathway framework LA Clerbaux, MC Albertini, N Amigo, A Beronius, GFG Bezemer, ... Journal of Clinical Medicine 11 (15), 4464, 2022 | 25 | 2022 |
| Alpha-Bazin, B.(2019). Evaluation of sample preparation methods for fast proteotyping of microorganisms by tandem mass spectrometry K Hayoun, D Gouveia, L Grenga, O Pible, J Armengaud Front. Microbiol 10, 1985 | 25 | 1985 |
| Mechanisms leading to gut dysbiosis in COVID-19: current evidence and uncertainties based on adverse outcome pathways LA Clerbaux, J Filipovska, A Muñoz, M Petrillo, S Coecke, MJ Amorim, ... Journal of clinical medicine 11 (18), 5400, 2022 | 24 | 2022 |
| Taxonomical and functional changes in COVID‐19 faecal microbiome could be related to SARS‐CoV‐2 faecal load L Grenga, O Pible, G Miotello, K Culotta, S Ruat, MA Roncato, F Gas, ... Environmental Microbiology 24 (9), 4299-4316, 2022 | 24 | 2022 |
| Metaproteomics to decipher CF host-microbiota interactions: overview, challenges and future perspectives P Hardouin, R Chiron, H Marchandin, J Armengaud, L Grenga Genes 12 (6), 892, 2021 | 22 | 2021 |
| FtsQ interaction mutants: a way to identify new antibacterial targets L Grenga, G Guglielmi, S Melino, P Ghelardini, L Paolozzi New biotechnology 27 (6), 870-881, 2010 | 21 | 2010 |
| Proteomics in the COVID‐19 battlefield: first semester check‐up L Grenga, J Armengaud Proteomics 21 (1), 2000198, 2021 | 20 | 2021 |
| Gut as an alternative entry route for SARS-CoV-2: current evidence and uncertainties of productive enteric infection in COVID-19 LA Clerbaux, SA Mayasich, A Muñoz, H Soares, M Petrillo, MC Albertini, ... Journal of clinical medicine 11 (19), 5691, 2022 | 15 | 2022 |
| Analyzing the complex regulatory landscape of Hfq–an integrative, multi-omics approach L Grenga, G Chandra, G Saalbach, CV Galmozzi, G Kramer, JG Malone Frontiers in microbiology 8, 1784, 2017 | 15 | 2017 |
